Application

19170240 · METABOLICALLY OPTIMIZED CELL CULTURE

Filed 2025-04-04 · Granted · Patent 12545717 (2026-02-10) The official file ↗The patent and its PDF ↗ · Art unit 1631 · Examiner Mark Lance Shibuya Typical · CPC C07K 16/00 · REGENERON PHARMACEUTICALS, INC. · Scully, Scott, Murphy & Presser, P.C.

Office actions

first was Notice of allowance

RCEs

no appeal

To first action

6.4 mo

to disposition 10.3 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.